Search Results 151-160 of 20606 for colitis

1. A Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA) - Mayo Clinic

   A Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA) ... Colitis (UC) or Crohn's disease (CD).

2. AMG 181 Phase 2 Study in Subjects with Moderate to Severe Ulcerative Colitis - Mayo Clinic

   AMG 181 Phase 2 Study in Subjects with Moderate to Severe Ulcerative Colitis · More about research at Mayo Clinic · Mayo Clinic Footer.

3. Mirikizumab-mrkz (intravenous route, subcutaneous route) - Side effects & dosage - Mayo Clinic

   Mirikizumab-mrkz injection is used to treat moderate to severe active Crohn's disease and ulcerative colitis. This medicine is available only with your ...

4. A Study of the Effectiveness of Methotrexate as Initial Treatment and Maintenance of a Steroid Free Remission in Ulcerative Colitis - Mayo Clinic

   A Study of the Effectiveness of Methotrexate as Initial Treatment and Maintenance of a Steroid Free Remission in Ulcerative Colitis · More about research at Mayo ...

5. A Study to Evaluate the Safety and Effectiveness of Ustekinumab as Initial or Maintenance Therapy for Patients with Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

   ... Colitis. Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo Clinic info; More information. Overview. Tab Title ...

6. A Study to Evaluate the Accuracy of the Length-109 Probe Set Panel (a Genetic Test) in Predicting Response to Golimumab in Participants with Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

   ... Colitis. Print details. Share; Facebook · Twitter. Overview; Participation ... colitis (UC). Participation eligibility. Participant eligibility includes age ...

7. A Study to Evaluate the Effectiveness, Safety and Movement of Ustekinumab in Pediatric Patients with Ulcerative Colitis - Mayo Clinic

   The global primary objectives of this study are, in pediatric participants with moderately to severely active ulcerative colitis (UC):. To evaluate the efficacy ...

8. Etrasimod (oral route) - Side effects & dosage - Mayo Clinic

   Description. Etrasimod is used to treat moderate to severe active ulcerative colitis. This medicine is available only with your doctor's prescription. This ...

9. Mayo Clinic Q&A: What does an IBD diagnosis mean for me?

   Ulcerative colitis typically affects the colon and rectum, and it leads to the development of sores called ulcers. Crohn's disease primarily affects the ...

10. Infliximab-abda (intravenous route) - Side effects & uses - Mayo Clinic

    Description. Infliximab-abda injection is used in adults to treat Crohn's disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, ...